SG50677A1 - Chondroitinase process for preparing the same and pharmaceutical composition comprising the same - Google Patents
Chondroitinase process for preparing the same and pharmaceutical composition comprising the sameInfo
- Publication number
- SG50677A1 SG50677A1 SG1996008458A SG1996008458A SG50677A1 SG 50677 A1 SG50677 A1 SG 50677A1 SG 1996008458 A SG1996008458 A SG 1996008458A SG 1996008458 A SG1996008458 A SG 1996008458A SG 50677 A1 SG50677 A1 SG 50677A1
- Authority
- SG
- Singapore
- Prior art keywords
- same
- chondroitinase
- chondroitinase abc
- crystallizable
- sds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/02—Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
- C12Y402/02004—Chondroitin ABC lyase (4.2.2.4), i.e. chondroitinase
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
- G03C1/04—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with macromolecular additives; with layer-forming substances
- G03C1/047—Proteins, e.g. gelatine derivatives; Hydrolysis or extraction products of proteins
- G03C2001/0471—Isoelectric point of gelatine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/873—Proteus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19288292 | 1992-06-26 | ||
JP31098092A JP3895782B2 (ja) | 1992-10-26 | 1992-10-26 | コンドロイチナーゼ組成物およびそれを含有する注射用製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG50677A1 true SG50677A1 (en) | 1998-07-20 |
Family
ID=26507572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG1996008458A SG50677A1 (en) | 1992-06-26 | 1993-06-25 | Chondroitinase process for preparing the same and pharmaceutical composition comprising the same |
Country Status (10)
Country | Link |
---|---|
US (3) | US5496718A (de) |
EP (1) | EP0576294B1 (de) |
KR (1) | KR100280779B1 (de) |
AT (1) | ATE192486T1 (de) |
CA (1) | CA2099138C (de) |
DE (1) | DE69328519T2 (de) |
DK (1) | DK0576294T3 (de) |
ES (1) | ES2146600T3 (de) |
RU (1) | RU2144833C1 (de) |
SG (1) | SG50677A1 (de) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5496718A (en) * | 1992-06-26 | 1996-03-05 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Chondroitinase ABC isolated from proteus vulgaris ATCC 6896 |
JP3419811B2 (ja) * | 1993-02-24 | 2003-06-23 | マルハ株式会社 | コンドロイチナーゼ遺伝子 |
US7008783B1 (en) | 1992-09-22 | 2006-03-07 | Maruha Corporation | Gene encoding chondroitinase ABC and uses therefor |
CA2161125A1 (en) * | 1993-04-23 | 1994-11-10 | Michael Joseph Ryan | Cloning and expression of the chondroitinase i and ii genes from p. vulgaris |
AU1176595A (en) * | 1993-11-12 | 1995-05-29 | International Technology Management Associates, Ltd. | Methods of repairing connective tissues |
US5498536A (en) * | 1994-04-22 | 1996-03-12 | American Cyanamid Company | Chondroitinase II from Proteus vulgaris |
US5525500A (en) * | 1994-04-22 | 1996-06-11 | American Cyanamid Company | Chromatographic process for the copurification of chondroitinase I and II proteins from Proteus vulgaris |
AU2428195A (en) * | 1994-04-22 | 1995-11-16 | American Cyanamid Company | Chondroitinases i and ii, methods of preparation, and use thereof |
US5888798A (en) * | 1995-06-07 | 1999-03-30 | American Cyanamid Company | Chondroitinase I and chondroitinase II producing mutants of P. vulgaris |
EP0747469A1 (de) * | 1995-06-08 | 1996-12-11 | The Procter & Gamble Company | Chondroitinase enthaltende Reinigungszusammensetzungen |
DE69829605T2 (de) * | 1997-05-02 | 2006-02-09 | Seikagaku Corp. | Chondroitinase enthaltende Zusammensetzungen |
JPH1149698A (ja) | 1997-07-31 | 1999-02-23 | Santen Pharmaceut Co Ltd | 安定性を向上させたラクトフェリンの水性製剤 |
US6063378A (en) * | 1997-08-22 | 2000-05-16 | Seikagaku Corporation | Therapeutic agent for herniated intervertebral disc |
DE60038386T2 (de) | 1999-09-08 | 2009-04-23 | Chugai Seiyaku K.K. | Stabile proteinlösung abgefüllt in einem behältnis aus hydrophobem harz und eine methode zur stabilisierung derselben |
WO2002099193A1 (fr) | 2001-06-01 | 2002-12-12 | Mitsubishi Paper Mills Limited | Papier faisant intervenir un element d'echange thermique total |
JP4749667B2 (ja) | 2001-08-13 | 2011-08-17 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | 神経組織の修復を促進するための材料および方法 |
GB0205022D0 (en) | 2002-03-04 | 2002-04-17 | Univ Cambridge Tech | Materials and methods for the treatment of cns damage |
EP1575548B1 (de) | 2002-05-04 | 2011-03-09 | Acorda Therapeutics, Inc. | Zusammensetzungen und verfahren zur förderung des neuronalen wachstums |
CA2493509C (en) * | 2002-06-03 | 2010-03-09 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from chondroitinase b |
DE60337009D1 (de) * | 2002-08-15 | 2011-06-16 | Acorda Therapeutics Inc | Chimärisches protein |
EP2218779A1 (de) * | 2002-12-16 | 2010-08-18 | Halozyme, Inc. | Humanes Chondrotinaseglykoprotein (CHASEGP), Verfahren zu dessen Herstellung und pharmazeutische Zusammensetzungen, die dieses umfassen |
US20090123367A1 (en) * | 2003-03-05 | 2009-05-14 | Delfmems | Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases |
PL2177620T3 (pl) * | 2003-03-05 | 2015-05-29 | Halozyme Inc | Rozpuszczalna glikoproteina o aktywności hialuronidazy (sHASEGP), sposób jej wytwarzania, zastosowania oraz zawierające ją kompozycje farmaceutyczne |
US20060104968A1 (en) * | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
US7871607B2 (en) * | 2003-03-05 | 2011-01-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
US7959914B2 (en) | 2003-05-16 | 2011-06-14 | Acorda Therapeutics, Inc. | Methods of reducing extravasation of inflammatory cells |
EP3514238B1 (de) | 2003-05-16 | 2021-05-05 | Acorda Therapeutics, Inc. | Proteoglycan-abbauende mutanten zur behandlung des zns |
PL1631234T3 (pl) * | 2003-05-16 | 2012-02-29 | Acorda Therapeutics Inc | Kompozycje i sposoby leczenia uszkodzeń OUN |
GB0403247D0 (en) | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
WO2005087920A2 (en) * | 2004-03-10 | 2005-09-22 | Massachusetts Institute Of Technology | Recombinant chondroitinase abc i and uses thereof |
US8226941B2 (en) * | 2004-05-18 | 2012-07-24 | Acorda Therapeutics, Inc. | Methods of purifying chondroitinase and stable formulations thereof |
WO2005122734A2 (en) * | 2004-06-14 | 2005-12-29 | The Research Foundation Of State University Of New York | Nanosphere/microsphere delivery system for the treatment of spinal cord injury |
US20060110788A1 (en) * | 2004-10-01 | 2006-05-25 | Invitrogen Corporation | Feeding buffers, systems, and methods for in vitro synthesis of biomolecules |
ES2393748T3 (es) | 2005-09-26 | 2012-12-27 | Acorda Therapeutics, Inc. | Composiciones y métodos de uso de condroitinasa ABCI mutantes |
WO2007063691A1 (ja) | 2005-11-29 | 2007-06-07 | Sanyo Chemical Industries, Ltd. | 溶菌剤 |
WO2008045970A2 (en) | 2006-10-10 | 2008-04-17 | Acorda Therapeutics, Inc. | Compositions and methods of using chondroitinase abci mutants |
US20110059508A1 (en) | 2007-06-29 | 2011-03-10 | National University Corporation Nagoya University | Improving agent for dysfunction due to neuropathy and rho kinase activation inhibitor |
US20090286289A1 (en) * | 2008-03-10 | 2009-11-19 | Pang Danny Z | Production of Hyaluronate Unsaturated Disaccharides and its Application |
PL2653168T3 (pl) * | 2010-12-13 | 2015-07-31 | Seikagaku Kogyo Co Ltd | Chondroitynaza ABC do leczenia przepukliny dysku |
DK3199175T3 (da) | 2014-09-27 | 2022-06-13 | Sumitomo Pharma Co Ltd | Farmaceutisk sammensætning til injektion |
US9796970B1 (en) | 2017-04-24 | 2017-10-24 | Advantek Serum Laboratories Ltd. | Production of high purity chondroitinase ABC |
EP3760220A4 (de) | 2018-02-28 | 2022-01-19 | Seikagaku Corporation | Packung und verfahren zur herstellung davon |
JP7321142B2 (ja) | 2018-02-28 | 2023-08-04 | 生化学工業株式会社 | 医薬組成物、包装体及びその製造方法 |
WO2022003565A1 (en) * | 2020-07-01 | 2022-01-06 | Medimmune, Llc | Detergent and method for purifying a biotherapeutic |
CN114409731B (zh) * | 2022-01-05 | 2023-08-11 | 浙江省农业科学院 | 同时具有激活乙醇脱氢酶和乙醛脱氢酶活性的两种多肽 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3549500A (en) * | 1967-07-22 | 1970-12-22 | Seikagaku Kogyo Co Ltd | Novel chondroitinase and method of its recovery |
JPS4832351B1 (de) * | 1968-06-12 | 1973-10-05 | ||
JPS4713704Y1 (de) * | 1971-09-29 | 1972-05-18 | ||
JPS6031479B2 (ja) * | 1978-02-10 | 1985-07-22 | 生化学工業株式会社 | 純コンドロイチナ−ゼcの製造法 |
JPS6031478B2 (ja) * | 1978-02-10 | 1985-07-22 | 生化学工業株式会社 | 純コンドロイチナ−ゼbの製造法 |
EP0009781B2 (de) * | 1978-09-29 | 1986-04-23 | Mitsubishi Kasei Corporation | Verfahren zur Reinigung langkettiger Acyl-Coenzym-A-Synthetase und das so gereinigte Enzym, Acyl-CoA-Synthetase |
CA1221328A (en) * | 1983-04-21 | 1987-05-05 | Robert K. Scopes | Enzyme extraction and purification processes |
US4696816A (en) * | 1985-11-07 | 1987-09-29 | Brown Mark D | Method for treating intervertebral disc displacement with enzymes |
JPS62122588A (ja) * | 1985-11-22 | 1987-06-03 | Taiyo Fishery Co Ltd | 純コンドロイチナ−ゼの製造法 |
JP2726275B2 (ja) * | 1988-08-24 | 1998-03-11 | 生化学工業株式会社 | グリコサミノグリカン分解酵素の精製法 |
JP2919496B2 (ja) * | 1989-08-24 | 1999-07-12 | 生化学工業株式会社 | 新規コンドロイチン硫酸分解酵素、それらを産生する微生物並びにそれらの製法 |
JP3140797B2 (ja) * | 1991-04-26 | 2001-03-05 | 生化学工業株式会社 | 安定化コンドロイチナーゼabc、その保存方法及び治療剤 |
US5496718A (en) * | 1992-06-26 | 1996-03-05 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Chondroitinase ABC isolated from proteus vulgaris ATCC 6896 |
-
1993
- 1993-06-23 US US08/082,853 patent/US5496718A/en not_active Expired - Lifetime
- 1993-06-25 CA CA002099138A patent/CA2099138C/en not_active Expired - Lifetime
- 1993-06-25 SG SG1996008458A patent/SG50677A1/en unknown
- 1993-06-25 KR KR1019930011667A patent/KR100280779B1/ko not_active IP Right Cessation
- 1993-06-25 RU RU93046317A patent/RU2144833C1/ru active
- 1993-06-25 EP EP93304979A patent/EP0576294B1/de not_active Expired - Lifetime
- 1993-06-25 DK DK93304979T patent/DK0576294T3/da active
- 1993-06-25 DE DE69328519T patent/DE69328519T2/de not_active Expired - Lifetime
- 1993-06-25 ES ES93304979T patent/ES2146600T3/es not_active Expired - Lifetime
- 1993-06-25 AT AT93304979T patent/ATE192486T1/de active
-
1995
- 1995-05-18 US US08/443,675 patent/US5763205A/en not_active Expired - Lifetime
-
1997
- 1997-07-07 US US08/888,530 patent/US6184023B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US5763205A (en) | 1998-06-09 |
DK0576294T3 (da) | 2000-10-09 |
US5496718A (en) | 1996-03-05 |
EP0576294B1 (de) | 2000-05-03 |
AU669528B2 (en) | 1996-06-13 |
DE69328519D1 (de) | 2000-06-08 |
CA2099138C (en) | 1998-09-22 |
DE69328519T2 (de) | 2000-09-14 |
ES2146600T3 (es) | 2000-08-16 |
ATE192486T1 (de) | 2000-05-15 |
US6184023B1 (en) | 2001-02-06 |
KR100280779B1 (ko) | 2001-02-01 |
KR940005793A (ko) | 1994-03-22 |
RU2144833C1 (ru) | 2000-01-27 |
EP0576294A3 (en) | 1994-08-17 |
EP0576294A2 (de) | 1993-12-29 |
CA2099138A1 (en) | 1993-12-27 |
AU4146493A (en) | 1994-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG50677A1 (en) | Chondroitinase process for preparing the same and pharmaceutical composition comprising the same | |
RU93046317A (ru) | Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции | |
Dimuzio et al. | Phosphophoryns—major noncollagenous proteins of rat incisor dentin | |
Dayton et al. | A Ca2+ ion-activated protease possibly involved in myofibrillar protein turnover. Purification from porcine muscle | |
DK0447585T4 (da) | Fremgangsmåde til fremstilling af et intravenøst tolerant immunglobulin-G-præparat | |
ATE173478T1 (de) | Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung | |
ES8702432A1 (es) | Procedimiento para la purificacion de una proteina | |
DK426386D0 (da) | Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer | |
Joubert | Snake venom toxins: the amino acid sequences of two toxins from Ophiophagus hannah (King Cobra) venom | |
EP0215625A3 (en) | Protein recovery | |
ES2058538T3 (es) | Compuestos de proteina a purificados y procedimiento para su preparacion. | |
JPS63503352A (ja) | タンパク質の精製 | |
OGILIVE et al. | Isolation and Characterization of Lactose-Binding Lectins from the Venoms of the Snakes Lachesis inuta and Dendroaspisjamesonii | |
DK0425082T3 (da) | Vacciner | |
YU172185A (en) | Process for obtaining monoclonic anti-bodies | |
DK525384D0 (da) | Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat | |
JPS646292A (en) | Manufacture of active-form protein | |
Takahashi et al. | Purification and characterization of anticomplement factor (cobra venom factor) from the Naja naja atra venom | |
Lenaz et al. | Studies on mitochondrial structural protein: III. Physical characterization of the structural proteins of beef heart and beef liver mitochondria | |
Wier et al. | Aproliferin--a human plasma protein that induces the irreversible loss of proliferative potential associated with terminal differentiation. | |
HU904388D0 (en) | Method for recovering recombinant proteins | |
EP0085220A3 (de) | Verfahren zur Reinigung des Hormons der vorderen Hypophyse | |
Lester et al. | Heterogeneity of human α-fetoprotein as revealed by isoelectric focusing in urea-containing gels | |
KR100371976B1 (ko) | 혈장헤파린결합단백질-70 | |
DK412389D0 (da) | Fremgangsmaade til udvinding af oprenset epi protein fra en fermenteringsoploesning |